Daniel Ginestet
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 14
- Pharmacology 11
- Treatment of Major Depression 9
- Cannabis and Cannabinoid Research 2
- Co-authors
- Julien‐Daniel Guelfi (2 shared papers)Emmanuelle Corruble (1 shared paper)André Féline (2 shared papers)J. L. Martinot (1 shared paper)Christian Trichard (1 shared paper)P. Hardy (1 shared paper)M.C. Masure (1 shared paper)H. Löo (7 shared papers)
- Journals
- L Encéphale (1 paper)Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry (1 paper)Journal of Affective Disorders (1 paper)European Psychiatry (1 paper)American Journal of Psychiatry (1 paper)
- Partner nations
- France
In The Last Decade
Daniel Ginestet
33 papers receiving 544 citations
Peers
Comparison fields: 5 of 51
- Biological Psychiatry 107
- Psychiatry and Mental health 175
- Pharmacology 122
- Behavioral Neuroscience 18
- Clinical Psychology 138
Countries citing papers authored by Daniel Ginestet
This map shows the geographic impact of Daniel Ginestet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ginestet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ginestet more than expected).
Fields of papers citing papers by Daniel Ginestet
This network shows the impact of papers produced by Daniel Ginestet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ginestet. The network helps show where Daniel Ginestet may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Ginestet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 190 | |
| 2 | 1996 | 153 | |
| 3 | 1989 | 136 | |
| 4 | Fluoxetine in endogenous depression and melancholia versus clomipramine. | 1989 | 15 |
| 5 | 1997 | 11 | |
| 6 | 1999 | 9 | |
| 7 | [2 cases of amineptine dependence]. | 1984 | 7 |
| 8 | [Neuro-psychic effects of operations with prolonged circulatory arrest under deep hypothermia (neuro-psychiatric, psychometric and electroencephalographic balance)]. | 1961 | 6 |
| 9 | [Delusions of negation: 4 case reports]. | 1994 | 6 |
| 10 | [A new neuroleptic formula, dibenzothiazepine. (Clinical and electroencephalographic study)]. | 1966 | 5 |
| 11 | [Apropos of 16 cerebral tumors observed over 10 years among the entrants to a women's department]. | 1968 | 5 |
| 12 | [Clinical pharmacology of delta-9-tetra-hydro-cannabinol in healthy volunteers with polygraphic control]. | 1974 | 4 |
| 13 | [Trial of verification of the thymoanaleptic action of hypothalamic thyrostimulin (thyrotropin releasing factor of TRF) in melancholic states]. | 1975 | 4 |
| 14 | [2 years of experience with imipramine]. | 1961 | 3 |
| 15 | [Comparison of clinical effects of delta-9-tetrahydrocannabinol with the classic effects of hashish]. | 1975 | 3 |
| 16 | [Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics]. | 1975 | 3 |
| 17 | ["Heat stroke" and/or "Malin's syndrome" in a patient treated with fluphenazine decanoate]. | 1977 | 3 |
| 18 | [Neuropsychological changes and psychiatric complications observed in a population of patients with liver transplantation]. | 1990 | 3 |
| 19 | [Clinical and electroencephalographic study of neuroleptic dibenzothiazepine derivative: HF 21.59]. | 1965 | 2 |
| 20 | [Clinical study of oxaflumazine; its place among the neuroleptics]. | 1971 | 2 |
About Daniel Ginestet
Daniel Ginestet is a scholar working on Psychiatry and Mental health, Pharmacology, Clinical Psychology, Critical Care and Intensive Care Medicine and Biological Psychiatry, having authored 39 papers that have together received 592 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (14 papers), Treatment of Major Depression (9 papers), Psychoanalysis and Psychopathology Research (2 papers), Cannabis and Cannabinoid Research (2 papers), Historical Psychiatry and Medical Practices (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Clinical Laboratory Practices and Quality Control (1 paper) and Circadian rhythm and melatonin (1 paper). The work is most often cited by research in Biological Psychiatry (107 citations), Psychiatry and Mental health (175 citations), Pharmacology (122 citations), Behavioral Neuroscience (18 citations) and Clinical Psychology (138 citations). Daniel Ginestet has collaborated with scholars based in France. Frequent co-authors include Julien‐Daniel Guelfi, Emmanuelle Corruble, André Féline, J. L. Martinot, Christian Trichard, P. Hardy, M.C. Masure, H. Löo, E. Zarifian and Lucienne Chatenoud. Their work appears in journals such as L Encéphale, Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry, Journal of Affective Disorders, European Psychiatry and American Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.